Helen Collins sold $192K of Enliven Therapeutics stock
By AlphaYouPublished Form 4
Collins Helen Louise
Reporting filer
Helen Louise Collins reported selling 5,000 shares of Enliven Therapeutics, Inc. for about $192K ($38.47 a share on average). Form 4 filed Oct 21, 2026 lists 3 entries.
See the price move since this trade →
- Disclosed
- Oct 21, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Collins Helen Louise | 2026-10-19 | M | Exercise or conversion | 5000 | 2.48 | 30,000 | 2 days | Filed terms
|
| Common Stock | Collins Helen Louise | 2026-10-19 | S | Sale | 5000 | 38.4684 | 25,000 | 2 days | Filed terms
|
| Stock Option (right to buy) (derivative) | Collins Helen Louise | 2026-10-19 | M | Exercise or conversion | 5000 | 0 | 101,268 | 2 days | Filed terms
|
Common Stock
- Owner
- Collins Helen Louise
- Date
- 2026-10-19
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 5000
- Price
- 2.48
- Following holdings
- 30,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-19
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Shares: 5000
- transaction Price Per Share: 2.48
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 30000
- id: F2
- direct Or Indirect Ownership: D
- nature Of Ownership:
Common Stock
- Owner
- Collins Helen Louise
- Date
- 2026-10-19
- Code
- S
- Action
- Sale
- Quantity
- 5000
- Price
- 38.4684
- Following holdings
- 25,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-19
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 5000
- transaction Price Per Share: 38.4684
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 25000
- id: F4
- direct Or Indirect Ownership: D
- nature Of Ownership:
Stock Option (right to buy) (derivative)
- Owner
- Collins Helen Louise
- Date
- 2026-10-19
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 5000
- Price
- 0
- Following holdings
- 101,268
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 2.48
- transaction Date: 2026-10-19
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Shares: 5000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F5
- expiration Date: 2031-06-17
- underlying Security Title: Common Stock
- underlying Security Shares: 5000
- shares Owned Following Transaction: 101268
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Collins Helen Louise: CHIEF MEDICAL OFFICER.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2025.
- F2: Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- F3: This transaction was executed in multiple trades at prices ranging from $37.785 to $38.75. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- F4: These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- F5: All of the shares subject to this option are fully vested and exercisable as of the date hereof.
Original sources
Prepared automatically from public filing data. Report a correction.